Calcimedica Director Fred A. Middleton Acquires 248,972 Common Shares Worth $200,000

CalciMedica Advances Auxora After Favorable FDA Safety Review

Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)

CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review

CalciMedica Amends Loan, Issues New Equity Warrants

CalciMedica announces $49M private placement

Calcimedica - Proceeds to Support Phase 1B Auxora Study in Pah and Cm5480 Ind Clearance, Data Expected Mid-2027

Calcimedica - Anticipates Cash Runway into Second Half of 2027 with Upfront Proceeds

Calcimedica Announces Private Placement Financing for up to Approximately $49 Million to Advance Pulmonary Hypertension Program

Calcimedica - FDA Review Allows Calcimedica to Continue Dosing Auxora in Kourage Trial

Calcimedica Announces Clinical Development of Auxora May Proceed Following FDA Review of Kourage Trial Interim Safety Data

Calcimedica - Expects FDA Feedback on Auxora Pancreatitis Program in Q3 2026

Calcimedica - Lender Extends Interest-only Period to Sept 30, 2027 and Maturity to Sept 1, 2029 - SEC Filing

Calcimedica - Enters First Amendment to Loan and Security Agreement on June 23, 2026 - SEC Filing

Calcimedica Issues Unregistered Warrant to Buy 1,000,000 Shares at USD 1 Each

Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC)

Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA)

CalciMedica Inc reports results for the quarter ended March 31 - Earnings Summary

CalciMedica Q1 EPS $0.30 Beats $(0.28) Estimate

CalciMedica posts Q1 profit on higher other income, lower expenses